Genes & Cancer | Pathogenesis to management of hepatocellular carcinoma
BUFFALO, NY- January 6, 2023 – A new review was published in Genes & Cancer on December 13, 2022, entitled, ...
Tag: hepatocellular
Oncotarget | Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
“In conclusion, our study demonstrate that plasma GH represents a candidate biomarker for predicting treatment outcomes in patients with advanced ...
HKUMed discovers a novel immunotherapeutic target against hepatocellular carcinoma first time in the world
HKUMed researchers at AIDS Institute, Department of Microbiology and Department of Surgery, School of Clinical Medicine, and School of Biomedical ...
Oncotarget | Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis
“The current and previous findings provide a rationale for further investigations into the potential utility of leucine, valine, and tryptophan ...
Safety, efficacy of robotic vs open liver resection for hepatocellular carcinoma
About The Study: The findings of this study comparing robotic liver resection with open liver resection suggest that robotic liver resection ...
Contrast-enhanced ultrasound, perfluorobutane diagnoses high-risk hepatocellular carcinoma
Leesburg, VA, November 16, 2022—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), diagnostic performance of ...
Genes & Cancer | Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer
“A third of the global cancer deaths are attributed to primary liver cancer .” Credit: Zaidi et al. “A third ...
Machine learning models predict hepatocellular carcinoma treatment response
Leesburg, VA, August 17, 2022—According to ARRS’ American Journal of Roentgenology (AJR), machine learning models applied to presently underutilized imaging ...
New technology in recent clinical study aims toward earlier detection of hepatocellular carcinoma
Primary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the United States each ...
A CRISPR-Cas9 based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: cross-talk of FGF21 and the NRF2 pathway
This study is led by Xiujun Cai (Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine). ...
AGA recommends shared decision-making approach for treatment of hepatocellular carcinoma (HCC)
Bethesda, MD (Feb. 22, 2022) — Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, remains a deadly cancer ...
PSMA PET imaging more accurate than CT in detecting hepatocellular carcinoma
Reston, VA (September 30, 2021)—PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the detection of hepatocellular ...
-
New experimental treatment can stop the growth of schwannoma tumors
-
International group of scientists warns nuclear radiation has devastating impacts on ecosystems
-
Anu, previously gropod, awarded nearly $1 million competitive grant from the National Science Foundation
-
Null results research now published by major behavioral medicine journal
-
UK Scientists make major breakthrough in developing practical quantum computers that can solve big challenges of our time
-
USC Stem Cell-led studies point the way to broadly effective treatments for ALS